Skip to main content
Clinical Trials/NCT07713303
NCT07713303Not yet recruitingNot Applicable

An Open-label, Single-arm Interventional Study to Evaluate the Safety and Efficacy of a Probiotic-containing Cream in Children With Dry Skin

BioGaia AB1 site in 1 country40 target enrollmentStarted: September 1, 2026Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Sponsor
BioGaia AB
Enrollment
40
Locations
1
Primary Endpoint
Primary objective

Study Overview

Brief Summary

The DermaKIDS study is an open-label, single-arm interventional study designed to evaluate the safety and efficacy of a probiotic-containing cream in children with dry skin. Approximately 40 children aged from newborn to 7 years will be enrolled at two study sites in Portugal. Participants will apply the study cream twice daily for a period of four weeks under normal home-use conditions. The primary efficacy endpoint is the change in Overall Dry Skin Score (ODS) from baseline to the end of the study. Safety and efficacy will be assessed through investigator evaluations combined with weekly parent-reported diaries and standardized photographs.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
0 Months to 7 Years (Child)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Newborn - 7 years.
  • ODS ≥ 2 in the target area.
  • Parent/guardian able to comply with weekly diaries/photos and visits.
  • Signed ICF by parent/legal guardian; assent as required.

Exclusion Criteria

  • Topical medicated treatments on target area within 2 weeks.
  • Active skin infection or severe eczema flare at target site.
  • Known allergy to product components.
  • Participation in another study within 30 days.
  • Any condition judged by investigator to preclude participation.

Outcomes

Primary Outcomes

Primary objective

Time Frame: From Baseline to Week 4

Evaluate change in Overall Dry Skin Score (ODS) from baseline to Week 4 after regular application (twice daily, every day) of Probiotic skin ointment (Study Product) versus baseline.

Secondary Outcomes

  • Secondary objective(From baseline to week 4)

Investigators

Sponsor
BioGaia AB
Sponsor Class
Industry
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials